PT  - JOURNAL ARTICLE
AU  - Yi, Zhen
AU  - Jie, Gao
AU  - Kai, Cao
AU  - Jing, Shen
AU  - wei, Zhang
AU  - Yun, Dai
TI  - Theoretical derivation and clinical validation of the resolution limit of human eye to spherical lens change:A Self-controlled Study
AID  - 10.1101/2022.04.13.22273857
DP  - 2022 Jan 01
TA  - medRxiv
PG  - 2022.04.13.22273857
4099  - http://medrxiv.org/content/early/2022/04/16/2022.04.13.22273857.short
4100  - http://medrxiv.org/content/early/2022/04/16/2022.04.13.22273857.full
AB  - Background/Aims To deduce theoretically and verify the resolution limit of human eye to spherical lens change for more reasonable design of the trial lenses.Methods First, the resolution limit of discernible change in spherical power was derived based on the optical model. Then, the volunteers were observed to see if they could perceive the changes in spherical power as per the resolution limit and compare the difference in the best corrected visual acuity obtained with the resolution limit and interval of 0.25D.Results Assuming that the cone cell diameter is 3 μm and the pupil diameter of 4 mm, the theoretically resolution limit was 0.05D. When the diopter of spherical power was increased, the ratios of ability to perceive 0.05D spherical lens change were 98.3% and 96.7% in right and left eyes. When the diopter of spherical power was decreased, the ratios of ability to perceive 0.05D spherical lens change were 78.9% and 83.2% in right and left eyes. The best corrected visual acuity obtained with the 0.05 D interval trial lens was significantly better than in the 0.25 D interval on both eyes (Right eye -0.04±0.07 vs -0.02±0.06, t=6.729, P<0.001; Left eye -0.07±0.06 vs -0.04±0.06, t=8.825, P<0.001).Conclusion The resolution limit of human eye to spherical lens change was about 0.05D and the better corrected visual acuity can be obtained by adjusting the spherical power at an interval of 0.05D.What is already known on this topic At present, the spherical power is generally adjusted at 0.25D for optometry. In clinical practice, we find that a more than 80% of myopia patients with clear red prototypes will directly see clear green in case of a decrease by 0.25D, unable to achieve the red-green balance.What this study adds More than 80% of myopia patients can perceive the changes in spherical power as per 0.05D.How this study might affect research, practice or policy Adjusting the spherical power per 0.05 D can help us to achieve a higher full correction rate (>80%) and realize better visual acuity.[Synopsis/Precis]The resolution limit of human eye to spherical lens change is about 0.05D and better corrected visual acuity can be obtained by adjusting the spherical power at an interval of 0.05D than 0.25D.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialChiCTR2100047074Funding StatementBeijing Municipal Science and Technology Project (Z201100005520042)Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The research was approved by the Human Studies Committee at Beijing Tongren Hospital (Beijing, China) in accordance with the Code of Ethics of the World Medical Association (registration number: ChiCTR2100047074).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors